GAMCO Investors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.3M Sell
80,050
-364
-0.5% -$84.8K 0.18% 157
2026
Q1
$19.7M Sell
80,414
-1,352
-2% -$315K 0.19% 149
2025
Q4
$16.9M Sell
81,766
-609
-0.7% -$120K 0.16% 163
2025
Q3
$15.3M Sell
82,375
-4,207
-5% -$721K 0.15% 180
2025
Q2
$13.2M Sell
86,582
-132
-0.2% -$20.3K 0.13% 187
2025
Q1
$14.4M Sell
86,714
-6,220
-7% -$973K 0.16% 165
2024
Q4
$13.4M Sell
92,934
-3,647
-4% -$565K 0.14% 181
2024
Q3
$15.7M Sell
96,581
-1,781
-2% -$284K 0.16% 167
2024
Q2
$14.4M Sell
98,362
-6,101
-6% -$907K 0.16% 166
2024
Q1
$16.5M Sell
104,463
-3,679
-3% -$586K 0.17% 159
2023
Q4
$17M Sell
108,142
-5,354
-5% -$821K 0.18% 150
2023
Q3
$17.7M Sell
113,496
-19,588
-15% -$3.23M 0.2% 133
2023
Q2
$22M Sell
133,084
-8,199
-6% -$1.32M 0.23% 115
2023
Q1
$21.9M Sell
141,283
-14,625
-9% -$2.36M 0.24% 116
2022
Q4
$27.5M Buy
155,908
+757
+0.5% +$131K 0.3% 101
2022
Q3
$25.3M Buy
155,151
+17,607
+13% +$2.98M 0.3% 95
2022
Q2
$24.4M Buy
137,544
+40,201
+41% +$7.16M 0.27% 111
2022
Q1
$17.3M Sell
97,343
-4,460
-4% -$759K 0.16% 176
2021
Q4
$17.4M Sell
101,803
-897
-0.9% -$147K 0.15% 178
2021
Q3
$16.6M Sell
102,700
-2,403
-2% -$410K 0.15% 184
2021
Q2
$17.3M Sell
105,103
-4,593
-4% -$760K 0.15% 185
2021
Q1
$18M Sell
109,696
-5,974
-5% -$967K 0.16% 174
2020
Q4
$18.2M Sell
115,670
-3,250
-3% -$480K 0.17% 167
2020
Q3
$17.7M Sell
118,920
-4,475
-4% -$662K 0.2% 152
2020
Q2
$17.4M Sell
123,395
-10,118
-8% -$1.47M 0.2% 151
2020
Q1
$17.5M Sell
133,513
-6,380
-5% -$905K 0.21% 142
2019
Q4
$20.4M Sell
139,893
-16,830
-11% -$2.28M 0.16% 166
2019
Q3
$20.3M Sell
156,723
-5,126
-3% -$675K 0.17% 158
2019
Q2
$22.5M Buy
161,849
+16,345
+11% +$2.26M 0.17% 153
2019
Q1
$20.3M Sell
145,504
-26,863
-16% -$3.6M 0.16% 175
2018
Q4
$22.2M Sell
172,367
-9,621
-5% -$1.34M 0.19% 146
2018
Q3
$25.1M Sell
181,988
-1,106
-0.6% -$147K 0.17% 161
2018
Q2
$22.2M Sell
183,094
-7,657
-4% -$955K 0.15% 182
2018
Q1
$24.4M Sell
190,751
-16,625
-8% -$2.25M 0.16% 168
2017
Q4
$29M Sell
207,376
-40,299
-16% -$5.61M 0.18% 154
2017
Q3
$32.2M Sell
247,675
-8,610
-3% -$1.14M 0.2% 142
2017
Q2
$33.9M Sell
256,285
-4,170
-2% -$532K 0.22% 127
2017
Q1
$32.4M Buy
260,455
+2,869
+1% +$343K 0.21% 132
2016
Q4
$29.7M Sell
257,586
-36,541
-12% -$4.22M 0.19% 147
2016
Q3
$34.7M Sell
294,127
-18,704
-6% -$2.27M 0.23% 128
2016
Q2
$37.9M Sell
312,831
-24,757
-7% -$2.81M 0.25% 119
2016
Q1
$36.5M Buy
337,588
+5,301
+2% +$549K 0.24% 125
2015
Q4
$34.1M Buy
332,287
+14,440
+5% +$1.45M 0.22% 122
2015
Q3
$29.7M Buy
317,847
+2,697
+0.9% +$261K 0.2% 134
2015
Q2
$30.7M Sell
315,150
-18,005
-5% -$1.8M 0.17% 159
2015
Q1
$33.5M Sell
333,155
-3,780
-1% -$384K 0.18% 158
2014
Q4
$35.2M Sell
336,935
-29,431
-8% -$3.1M 0.18% 152
2014
Q3
$39.1M Sell
366,366
-6,820
-2% -$707K 0.21% 135
2014
Q2
$39M Sell
373,186
-21,875
-6% -$2.21M 0.2% 140
2014
Q1
$38.8M Sell
395,061
-16,736
-4% -$1.55M 0.21% 135
2013
Q4
$37.7M Buy
411,797
+2,376
+0.6% +$219K 0.2% 141
2013
Q3
$35.5M Buy
409,421
+3,317
+0.8% +$298K 0.21% 143
2013
Q2
$34.9M Buy
+406,104
New +$34.5M 0.22% 134

Other funds holding JNJ

GAMCO Investors's JNJ Position: Q2 2026 in Review

GAMCO Investors reduced its Johnson & Johnson (JNJ) stake by 0.45% in Q2 2026, selling an estimated $84.8K and leaving 80,050 shares worth $20.3M. The position accounts for 0.18% of the portfolio, ranked #157.

GAMCO Investors first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $39.1M in Q3 2014. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • GAMCO Investors held 80,050 shares of Johnson & Johnson worth $20.3M as of Q2 2026.
  • GAMCO Investors sold 364 Johnson & Johnson shares in Q2 2026, an estimated $84.8K.
  • Johnson & Johnson made up 0.18% of GAMCO Investors's portfolio in Q2 2026, its #157 holding.
  • GAMCO Investors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • GAMCO Investors's Johnson & Johnson position peaked at $39.1M in Q3 2014.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on GAMCO Investors's 13F filing for Q2 2026, filed 12 Aug 2026.